Commenting on the study for heartwire, antiplatelet expert Dr Victor Serebruany (HeartDrug Research, Towson, MD) said: "This is an extremely important paper with a clear clinical message—abrupt ...

Please provide your email address to receive an email when new articles are posted on . In early 2009, the FDA announced an ongoing safety review of clopidogrel after receiving reports that the use of ...

Jacksonville, FL - Data from a pharmacodynamic study suggests that acute coronary syndrome (ACS) patients can be safely switched from maintenance clopidogrel (Plavix, Bristol-Myers ...

Add Yahoo as a preferred source to see more of our stories on Google. Clopidogrel is a once-a-day pill that is available under the brand names Grepid and Plavix Two million prescription for aspirin ...

For decades, aspirin has been the go‑to drug for preventing heart attacks and strokes. But recent research is turning that assumption on its head. Aspirin has been overtaken by another well-known ...

You have full access to this article via your institution. The Clopidogrel as Adjunctive Reperfusion Therapy–Thrombolysis In Myocardial Infarction study (CLARITY-TIMI) 28 trial was an international, ...

Clopidogrel is prescribed to help prevent cardiovascular events such as heart attack and stroke in certain adults. It’s a generic medication that's available as the brand-name drug Plavix. The drug ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In a pooled cohort of the two STOPDAPT-2 trials, among ...

Gaspoz et al. (June 6 issue) 1 present an interesting perspective on the problem of escalating health care costs. Their comparison between the cost effectiveness of aspirin and that of clopidogrel is ...

To the Editor: The conduct of the Clopidogrel and the Optimization of Gastrointestinal Events Trial (COGENT) by Bhatt and colleagues (Nov. 11 issue) 1 is timely. Previous nonrandomized studies have ...

Ticagrelor may not have an advantage over clopidogrel as part of a dual antiplatelet therapy (DAPT) regimen when it comes to treating ACS patients who have undergone PCI in everyday practice, a large ...

Background A 67-year-old man with supraventricular tachycardia associated with angina underwent coronary angiographic assessment. This investigation revealed mild coronary artery disease in his left ...